Notable Analyst Rating Changes 07/08: (BBRY) (LINE) (PGNX) Upgraded; (SSRI) (BSX) (INTC) Downgraded


Desjardins upgrades BlackBerry (Nasdaq: BBRY) from Long-Term Sell to Long-Term Hold. Click Here for more color.

BofA/Merrill Lynch boosts LINN Energy (Nasdaq: LINE) from Neutral to Buy.

Brean Capital upgraded Progenics Pharmaceuticals (Nasdaq: PGNX) from Hold to Buy.

Morgan Stanley upgraded (Nasdaq: PCLN) from Equalweight to Overweight with a price target of $1010. Click Here for more color.

For daily real-time Upgrades go to


Scotia Capital trims Silver Standard Resources (Nasdaq: SSRI) from Sector Perform to Underperform with a price target of $6.

Citi reduces Boston Scientific (NYSE: BSX) from Buy to Neutral.

Evercore Partners cuts Intel (Nasdaq: INTC) from Equal Weight to Underweight, moving its price target from $22 down to $20.

Needham & Company downgrades Flextronics (Nasdaq: FLEX) from Buy to Hold.

For daily real-time Downgrades go to


Aegis Capital initiates Alcobra Ltd. (Nasdaq: ADHD) with a Buy and $30 price target.

CLSA starts Emerson (NYSE: EMR) with a Outperform

JMP Securities begins Santarus (Nasdaq: SNTS) with a Market Outperform and $27 target.

Sterne Agee initiates 21st Century Fox (Nasdaq: FOXA) with a Buy and $36 target.

For daily real-time New Coverage go to

Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.

Join FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW *NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here begin ad tag (tile=12) -- End ad tag --

Sign Up

Get the InvestingChannel
Free e-Letter Today

Learn More

Independent market opinion, analysis and ideas - delivered every business day

Premium market opinions, analysis, and ideas - delivered every business day

Editor's Picks